-
Event / Presentation
2025.12.22
CEO Tomohiro Fujita Shares Insights on AI-Driven Bio-Production Strategy at FII PRIORITY Asia 2025
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
Event / Presentation
2025.11.28
CHITOSE to Present on Mammalian Cell Technologies at JAACT 2025 in Osaka
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
-
Event / Presentation
2025.07.17
Introduction Session Held for TU Delft and Leiden University Students and Faculty ー〈CHITOSE Official X Account〉
-
Event / Presentation
2025.06.03
CHITOSE Presents on Novel HAT Cell Line for AAV Manufacturing at ASGCT Annual Meeting
-
Event / Presentation
2025.04.25
CHITOSE Exhibited at FHA Food & Beverage 2025 in Singapore
-
Event / Presentation
2025.03.18
Ambassador of Japan to Malaysia Visits C4 and Chitose Agri Laboratory
-
Event / Presentation
2025.03.12
CHITOSE Participated in His Majesty’s Birthday Receptions Held at the Embassy of Japan in Malaysia and the Embassy of Japan in Brunei
-
Event / Presentation
2025.01.27
CEO Tomohiro Fujita Presented at the 19th Saudi-Japanese Business Council Meeting
